Literature DB >> 8829061

Preeclampsia. A nested, case-control study of risk factors and their interactions.

R Mittendorf1, K Y Lain, M A Williams, C K Walker.   

Abstract

OBJECTIVE: To study the risk factors for preeclampsia and their interactions. STUDY
DESIGN: We used a nested, case-control study design to analyze data collected in the Delivery Interview Program, 1977-1980, Boston Hospital for Women (now known as the Brigham and Women's Hospital), Boston. Cases (n = 386) of obstetrician-diagnosed preeclampsia were compared with randomly selected controls (n = 2,355). Using multiple logistic regression, we derived maximum likelihood estimates of adjusted odds ratios (ORs) and 95% confidence intervals (CIs).
RESULTS: The following risk factors were statistically significantly associated with preeclampsia: urinary tract infection (UTI) during pregnancy (OR 1.6, 95% CI 1.1-2.5), primiparity (OR 3.8, 95% CI 2.8-5.2), black race (OR 1.5, 95% CI 1.1-1.9), less than a high school education (OR 2.0, 95% CI 1.1-3.6), exposure to diethylstilbestrol in utero (OR 2.4, 95% CI 1.2-2.4), body mass index (kg/m2) > 30 (OR 2.7, 95% CI 1.6-4.4) and cigarette smoking (OR 0.6, 95% CI 0.5-0.8). When evaluating interactions between variables, we found that primiparas who had UTI during pregnancy were five times more likely (OR 5.3, 95% CI 2.9-9.7) to have preeclampsia than were primiparas who did not have UTI during pregnancy.
CONCLUSION: It is possible that the preeclampsia associated with some of the risk factors we identified could be modified by the use of prophylactic drugs or other interventions. The primipara with a UTI would be a most likely beneficiary.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8829061

Source DB:  PubMed          Journal:  J Reprod Med        ISSN: 0024-7758            Impact factor:   0.142


  21 in total

Review 1.  Pathophysiology and maternal biologic markers of preeclampsia.

Authors:  Jacques Massé; Yves Giguère; Abdelaziz Kharfi; Joël Girouard; Jean-Claude Forest
Journal:  Endocrine       Date:  2002-10       Impact factor: 3.633

2.  Maternal age and risk of labor and delivery complications.

Authors:  Patricia A Cavazos-Rehg; Melissa J Krauss; Edward L Spitznagel; Kerry Bommarito; Tessa Madden; Margaret A Olsen; Harini Subramaniam; Jeffrey F Peipert; Laura Jean Bierut
Journal:  Matern Child Health J       Date:  2015-06

Review 3.  Epidemiology of preeclampsia: impact of obesity.

Authors:  Arun Jeyabalan
Journal:  Nutr Rev       Date:  2013-10       Impact factor: 7.110

4.  Racial/ethnic differences in pregnancy-related hypertensive disease in nulliparous women.

Authors:  Gaurav Ghosh; Jagteshwar Grewal; Tuija Männistö; Pauline Mendola; Zhen Chen; Yunlong Xie; S Katherine Laughon
Journal:  Ethn Dis       Date:  2014       Impact factor: 1.847

5.  Microbial invasion of the amniotic cavity in preeclampsia as assessed by cultivation and sequence-based methods.

Authors:  Daniel B DiGiulio; Mariateresa Gervasi; Roberto Romero; Shali Mazaki-Tovi; Edi Vaisbuch; Juan Pedro Kusanovic; Kimberley S Seok; Ricardo Gómez; Pooja Mittal; Francesca Gotsch; Tinnakorn Chaiworapongsa; Enrique Oyarzún; Chong Jai Kim; David A Relman
Journal:  J Perinat Med       Date:  2010-09       Impact factor: 1.901

6.  The International Federation of Gynecology and Obstetrics (FIGO) initiative on pre-eclampsia: A pragmatic guide for first-trimester screening and prevention.

Authors:  Liona C Poon; Andrew Shennan; Jonathan A Hyett; Anil Kapur; Eran Hadar; Hema Divakar; Fionnuala McAuliffe; Fabricio da Silva Costa; Peter von Dadelszen; Harold David McIntyre; Anne B Kihara; Gian Carlo Di Renzo; Roberto Romero; Mary D'Alton; Vincenzo Berghella; Kypros H Nicolaides; Moshe Hod
Journal:  Int J Gynaecol Obstet       Date:  2019-05       Impact factor: 3.561

7.  The Role of Obstructive Sleep Apnea in Developing Gestational Hypertension and Preeclampsia.

Authors:  Laura Lungeanu-Juravle; Natalia Patrascu; Oana Claudia Deleanu; Mircea Cinteza
Journal:  Maedica (Bucur)       Date:  2016-12

8.  Antigen Analysis of Pre-Eclamptic Plasma Antibodies Using Escherichia Coli Proteome Chips.

Authors:  Te-Yao Hsu; Jyun-Mu Lin; Mai-Huong T Nguyen; Feng-Hsiang Chung; Ching-Chang Tsai; Hsin-Hsin Cheng; Yun-Ju Lai; Hsuan-Ning Hung; Chien-Sheng Chen
Journal:  Mol Cell Proteomics       Date:  2017-12-28       Impact factor: 5.911

Review 9.  Association between maternal infections and preeclampsia: a systematic review of epidemiologic studies.

Authors:  Luis O Rustveld; Sheryl F Kelsey; Ravi Sharma
Journal:  Matern Child Health J       Date:  2007-06-19

10.  Anti-angiogenic factors and pre-eclampsia in type 1 diabetic women.

Authors:  Y Yu; A J Jenkins; A J Nankervis; K F Hanssen; H Scholz; T Henriksen; B Lorentzen; T Clausen; S K Garg; M K Menard; S M Hammad; J C Scardo; J R Stanley; A Dashti; K May; K Lu; C E Aston; J J Wang; S X Zhang; J-X Ma; T J Lyons
Journal:  Diabetologia       Date:  2008-11-05       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.